Related Experiment Videos
Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
E Krauze1, L Brzezińska-Wcisło, G Kamińska-Winciorek
1Dermatological Departament of Silesian Medical Academy, 40-027 Katowice, ul. Francuska 20/24, Poland. ekrauze@slam.katowice.pl
Journal of the European Academy of Dermatology and Venereology : JEADV
|September 17, 2005
Summary
Pyoderma gangrenosum can be associated with acute myelogenous leukemia, a rare but serious comorbidity. This case highlights the importance of considering systemic diseases in pyoderma gangrenosum diagnosis.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Pyoderma gangrenosum (PG) is a rare inflammatory ulcerative skin condition.
- Malignant neoplasms occur in approximately 7% of PG cases.
- The coexistence of PG and acute myelogenous leukemia (AML) is uncommon.
Observation:
- A 26-year-old male presented with skin lesions on both tibiae in June 2001.
- Initial surgical treatment preceded the diagnosis of PG.
- The patient was admitted to the Dermatological Department in November 2001 due to severe dermatological and general condition.
Findings:
- Diagnosis of pyoderma gangrenosum was established based on clinical and biochemical findings.
- The patient was diagnosed with coexisting acute myelogenous leukemia.
- Initial treatment with cyclosporin A (200 mg/day) showed slight clinical improvement.
Implications:
- This case underscores the critical need for a comprehensive diagnostic approach in pyoderma gangrenosum.
- Early recognition of underlying systemic malignancies like AML is crucial for effective management.
- The study highlights the complex interplay between inflammatory skin disorders and hematologic malignancies.